Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.9K Buy
428
+392
+1,089% +$28.7K ﹤0.01% 724
2025
Q4
$2.9K Sell
36
-118
-77% -$9.49K ﹤0.01% 941
2025
Q3
$12.6K Sell
154
-33
-18% -$2.86K ﹤0.01% 767
2025
Q2
$17.1K Buy
187
+157
+523% +$14K ﹤0.01% 722
2025
Q1
$2.75K Sell
30
-58
-66% -$5.06K ﹤0.01% 967
2024
Q4
$7.49K Buy
88
+26
+42% +$2.28K ﹤0.01% 832
2024
Q3
$5.42K Buy
62
+26
+72% +$2.19K ﹤0.01% 837
2024
Q2
$2.84K Buy
+36
New +$2.96K ﹤0.01% 908

Other funds holding DOX

CVA Family Office's DOX Position: Q1 2026 in Review

CVA Family Office increased its Amdocs (DOX) stake by 1,089% in Q1 2026, buying an estimated $28.7K and bringing the position to 428 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

CVA Family Office first reported a position in DOX in Q2 2024 and has held it in 8 quarters since. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • CVA Family Office held 428 shares of Amdocs worth $27.9K as of Q1 2026.
  • CVA Family Office bought 392 Amdocs shares in Q1 2026, an estimated $28.7K.
  • Amdocs made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #724 holding.
  • CVA Family Office first reported a position in Amdocs in Q2 2024 and has held it in 8 quarters since.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.